A six-week, randomized, double-blind, quadruple-dummy parallel group multiple dose study comparing the efficacy and safety of tiotropium inhalation capsules plus formoterol inhalation capsules to salmeterol inhalation aerosol plus fluticasone inhalation aerosol in patients with chronic obstructive pulmonary disease (COPD)

Trial Profile

A six-week, randomized, double-blind, quadruple-dummy parallel group multiple dose study comparing the efficacy and safety of tiotropium inhalation capsules plus formoterol inhalation capsules to salmeterol inhalation aerosol plus fluticasone inhalation aerosol in patients with chronic obstructive pulmonary disease (COPD)

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Oct 2009

At a glance

  • Drugs Fluticasone propionate; Formoterol; Salmeterol; Tiotropium bromide
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2008 Primary endpoint 'Forced expiratory volume in 1 second' has been met.
    • 01 Aug 2008 Results published in Chest journal.
    • 09 Jan 2008 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top